1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-38-4-237
1993-04-01
2022-05-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/38/4/medmicro-38-4-237.html?itemId=/content/journal/jmm/10.1099/00222615-38-4-237&mimeType=html&fmt=ahah

References

  1. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. J Infect Dis 1991; 13:34–46
    [Google Scholar]
  2. Ziegler EJ, Fisher CJ Jr, Strung CL et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin—a randomized, double-blind, placebo-controlled trial. N Engl J Med 1991; 324:429–36
    [Google Scholar]
  3. Glauser MP, Zanetti G, Baumgartner J-D, Cohen J. Septic shock: pathogenesis. Lancet 1992; 338:732–6
    [Google Scholar]
  4. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/tumour necrosis factor antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662–4
    [Google Scholar]
  5. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i:355–7
    [Google Scholar]
  6. Ziegler EJ, McCutchan JA, Fierer J et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli . N Engl J Med 1982; 307:1225–30
    [Google Scholar]
  7. Baumgartner JD, Glauser MP. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. Rev Infect Dis 1987; 9:194–205
    [Google Scholar]
  8. Baumgartner JD, Glauser MP, McCutchan JA et al. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 1985; 2:59–63
    [Google Scholar]
  9. The Intravenous Immunoglobulin Study Group. Prophylactic administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection N Engl J Med 1992; 327234–40
    [Google Scholar]
  10. Warren HS, Danner RL, Munford RS. Sounding aboard: anti endotoxin antibodies. N Engl J Med 1992; 326:1153–7
    [Google Scholar]
  11. Siegel JP, Stein KE, Zoon KC. Anti-endotoxin monoclonal antibodies (letter). N Engl J Med 1992; 327:890–1
    [Google Scholar]
  12. Baumgartner JD, Heumann D, Gerain J, Weinbreck P, Grau GE, Glauser MP. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumour necrosis a and interleukin 6. J Exp Med 1990; 171:889–96
    [Google Scholar]
  13. Tonoli M, Davies KA, Appelmelk BJ, Walport MJ, Cohen J. In vitro binding of human monoclonal anti-lipid A antibody (HA-1A) to gram-negative bacteria. Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992 Abstract No. 10
    [Google Scholar]
  14. Wenzel R, Bone R, Fein A et al. Results of a second double blind randomized controlled trial of anti-endotoxin antibody E5 in gram-negative sepsis. Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy 1991 Abstract No. 1170
    [Google Scholar]
  15. Echtenacher B, Falk W, Mannel DN, Krammer PH. Requirement of endogenous tumour necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145:3762–6
    [Google Scholar]
  16. Opal SM, Fisher CJ, Slotman GJ et al. The phase II Interleukin-1 receptor antagonist (IL-lra) sepsis syndrome trial: analysis of clinical, cytokine, and microbial features with outcome. Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992 Abstract No. 1570
    [Google Scholar]
  17. Nadel S, Klein N, Heyderman R, Levin M. Endotoxin antibody for sepsis in infants. Lancet 1992; 339:678
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-38-4-237
Loading
/content/journal/jmm/10.1099/00222615-38-4-237
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error